(Q44431620)

English

New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels

scientific article published in January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

based on heuristic

inferred from title

author name string

Wang XL

1

1 reference

Europe PubMed Central

2 December 2017

Badenhop R

2

1 reference

Europe PubMed Central

2 December 2017

Humphrey KE

3

1 reference

Europe PubMed Central

2 December 2017

Wilcken DE

4

1 reference

Europe PubMed Central

2 December 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

2 December 2017

Genetic Epidemiology

1 reference

Europe PubMed Central

2 December 2017

13

1 reference

Europe PubMed Central

2 December 2017

1

1 reference

Europe PubMed Central

2 December 2017

1-10

1 reference

Europe PubMed Central

2 December 2017

Both the 5' untranslated region and the sequences surrounding the start site contribute to efficient initiation of translation in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Features in the 5' non-coding sequences of rabbit alpha and beta-globin mRNAs that affect translational efficiency

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

mRNA translation: influence of the 5' and 3' untranslated regions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Multivariate genetic analysis of high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Multivariate genetic analysis of apo AI concentration and HDL subfractions: evidence for major locus pleiotropy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Association of a polymorphism in the Apo AI gene promoter with hyperalphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Determinants of severity of coronary artery disease in Australian men and women

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

C to T and/or G to A transitions are responsible for loss of a MspI restriction site at the 5'-end of the human apolipoprotein AI gene

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2272%281996%2913%3A1%3C1%3A%3AAID-GEPI1%3E3.0.CO%3B2-D

21 January 2018

Identifiers

10.1002/(SICI)1098-2272(1996)13:1<1::AID-GEPI1>3.0.CO;2-D

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44431620&oldid=2023237013"